Cryptocurrency expert delves into the potential of AVXL stock, forecasting a possible $100 billion valuation on FDA approval. Also covering Micron, Walgreens Boots, and Levi Strauss in the financial landscape, this analysis highlights penny stock opportunities before a potential buyout. Stay tuned for market insights.